Trade Ideas August 20, 2026 07:14 AM

Lincoln National: Earnings Momentum, Cheap Multiples - A Tactical Long

Quality annuity flows and a high ROE trade at deep value metrics; trade with a clear stop as balance-sheet and cash-flow risks persist.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
LNC

Lincoln National (LNC) reported recurring strength in annuities and group protection that has pushed statutory earnings higher, yet the stock trades at a single-digit P/E and below-book valuation. We view LNC as a tactical long for income and value-oriented traders, with a trade plan that captures upside as the market re-rates the insurer while limiting downside with a defined stop.

Lincoln National: Earnings Momentum, Cheap Multiples - A Tactical Long
LNC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • LNC trades at a steep discount: P/E ~3.7, P/B ~0.73, EV/EBITDA ~4.7.
  • Company shows earnings power (EPS ~$11.85) and ROE near 20%, supported by annuities and group protection.
  • Trade plan: long at $43.50, stop $38.00, target $60.00, horizon long term (180 trading days).
  • Primary risks: negative free cash flow (~-$5.83B), leverage (debt/equity ~1.42), reserve and interest-rate sensitivity.

Hook & thesis

Lincoln National Corp. is offering a clear risk-reward right now: operating businesses showing earning power, a return on equity near 20%, and a juicy cash dividend, while the shares trade at a P/E below 4 and a price-to-book under 1. At $43.50 the market is pricing LNC like a distressed insurance name, but operating metrics and recent segment performance argue for a rerating toward more normal insurance multiples.

We therefore recommend a tactical long: enter at $43.50 with a stop at $38.00 and a target of $60.00, holding for the long term (180 trading days). The plan leans on valuation cheapness (EV/EBITDA ~4.7, P/B ~0.73) and recurring annuity cash flows, while protecting capital given weak free cash flow and leverage on the balance sheet.

What the company does and why it matters

Lincoln National is a diversified U.S. life insurer operating five segments: Annuities, Retirement Plan Services, Life Insurance, Group Protection, and Other Operations. Annuities provide tax-deferred accumulation and lifetime income products - a business that benefits when clients lock in guaranteed solutions and when the interest-rate environment stabilizes. Retirement Plan Services targets the defined-contribution market. Group Protection delivers employee-paid and employer-paid term life, disability and ancillary benefits.

Why the market should care: annuities and retirement products are sticky, fee-accretive businesses that can generate predictable margins once sales and ALM are aligned. That stable cash-flow profile usually commands higher multiples than LNC is currently getting. With a market cap around $8.3 billion and enterprise value near $14.26 billion, the stock's current multiples imply either a structural impairment that isn't obvious in reported returns or an opportunity to buy real earnings power at a discount.

Supporting evidence - the numbers

Key public metrics paint a specific picture:

  • Share price: $43.50 (current)
  • Market cap: roughly $8.32 billion
  • Earnings per share (trailing): $11.85; reported P/E roughly 3.7
  • Price-to-book: ~0.73
  • EV/EBITDA: 4.73
  • Dividend: $0.45 per quarter (next payable 11/02/2026), yield ~3.99%
  • Return on equity: ~19.99%
  • Free cash flow: negative ~-$5.83 billion (most recent figure)
  • Debt-to-equity: ~1.42

Those figures suggest the company is profitable on an accounting basis (high ROE, meaningful EPS) but has cash-flow dynamics and leverage that require scrutiny. The annuities and group protection segments have shown resilience in past quarters, and an earnings beat driven by annuities was reported on 08/02/2024. The stock’s 52-week range - low of $32.18 (03/03/2026) to a high of $47.67 (08/05/2026) - shows it can move decisively when sentiment shifts.

Valuation framing

Popping the hood on valuation: at $43.50 LNC trades at ~3.7x trailing earnings and below book. EV/EBITDA of 4.7 is low relative to most diversified insurers, and price-to-sales of ~0.43 signals the market is not paying for recurring premium flows. Put differently, a modest rerating back toward mid-single-digit P/E multiples would create meaningful upside even without EPS growth - and there's scope for EPS improvement if annuity spreads and fee income recover.

That said, low multiples are not justification alone. The balance sheet, reserve dynamics, and cash generation matter. Negative recent free cash flow and a meaningful leverage ratio explain much of the discount. Our base-case valuation argues the market should be willing to pay closer to a $55-$65 range if free cash flow normalizes or if management communicates a credible plan to convert accounting earnings into distributable cash.

Trade plan (actionable)

Direction: Long

Entry price: $43.50

Stop loss: $38.00

Target price: $60.00

Time horizon: long term (180 trading days) - this is a medium-to-long duration value trade that anticipates at least several quarters of improved operating cash flow or market recognition of the company's earnings quality. The horizon allows time for reserve/ALM adjustments, annuity spread normalization, or clearer capital allocation signals that would justify a re-rating.

Rationale for levels: the stop at $38 sits below the 50-day EMA and gives room for near-term volatility while cutting losses if downside accelerates. The $60 target assumes a re-rating to a still-conservative P/E near 5x on current EPS, which is achievable if FCF trends positive and concerns about reserves/leverage abate.

Catalysts

  • Improving annuity spreads and net investment income as portfolio positioning benefits from a stable or higher rate environment - this would lift margin and cash generation.
  • Quarterly results that show narrowing of the gap between accounting EPS and distributable cash flow; any step toward positive free cash flow would be a strong rerating trigger.
  • Capital actions or clearer buyback guidance - any credible signal that excess capital will be returned to shareholders would reduce the P/B discount.
  • Analyst upgrades and a return of investor appetite for financials/value stocks following a period of risk-off behavior.

Risks and counterarguments

We list several reasons this trade can fail and one explicit counterargument to our bullish thesis:

  • Negative free cash flow: Recent reported free cash flow is substantially negative (~-$5.83B). If this persists, the company may be forced to conserve capital, cut the dividend, or delay share repurchases - all negative for the equity.
  • Leverage and reserve risk: Debt-to-equity ~1.42 and the nature of life/annuity liabilities mean that adverse mortality, longevity, or actuarial reserve developments could force charges that wipe out the valuation cushion.
  • Interest-rate sensitivity: While higher rates can help annuity margins, rapid rate moves or a volatile macro backdrop can hurt new sales and reserves. Poor ALM execution could widen the gap between accounting earnings and economic capital.
  • Competitive pressures and distribution: Retirement plan services and annuities are competitive markets; failure to innovate or loss of market share (note industry rankings in plan sponsor homepages) could limit growth.
  • Counterargument - value trap possibility: Cheap multiples may reflect persistent structural cash-generation problems. If accounting earnings are not convertible to cash because of capital needs or regulatory constraints, the stock could remain cheap or fall further. This is the single most important counterargument and is why we use a firm stop and limit horizon.
  • Short interest and momentum risk: Short activity has been material in recent months, and bearish technicals (MACD shows negative histogram) can amplify downside if sentiment changes quickly.

What would change my mind

Positive signs that would increase conviction: a return to positive free cash flow on a trailing-12-month basis, a sustained improvement in annuity margins, or clear capital-return commitments from management (buybacks/dividend increases tied to cash flow). Conversely, evidence that cash flow deficits are structural, meaningful reserve charges, or dividend cuts would materially weaken the thesis and prompt an exit or short reconsideration.

Conclusion

Lincoln National is a high-conviction tactical long for disciplined value traders who can stomach insurance-sector noise. The company shows earnings power (EPS ~$11.85 and ROE near 20%), and the market is assigning deeply discounted multiples. That combination creates an asymmetric upside if cash generation and leverage concerns ease. But the trade is not without material risk - negative free cash flow and leverage mean this is not a buy-and-forget name. Use the entry at $43.50, enforce a $38 stop, and plan to hold for up to 180 trading days while actively monitoring cash-flow and reserve developments.

Quick reference table

Metric Value
Current price $43.50
Market cap $8.32B
EPS (trailing) $11.85
P/E ~3.7x
P/B ~0.73x
EV/EBITDA ~4.7x
Dividend yield ~3.99%
Free cash flow ~-$5.83B

Entry, stop, and target are actionable levels intended for disciplined traders. Monitor quarterly results and capital metrics closely while holding this trade.

Risks

  • Persistently negative free cash flow leading to dividend pressure or constrained capital returns.
  • Adverse reserve developments or mortality/longevity shocks that require material charges.
  • High leverage (debt-to-equity ~1.42) amplifying downside in a stressed market.
  • Interest-rate volatility that weakens annuity sales and leaves ALM mismatches unaddressed (could compress cash margins).

More from Trade Ideas

10x Genomics Upgraded - Turnaround Confirmed, Now Buy Atera Execution Aug 20, 2026 NICE: Profitable AI Growth Underpriced — A 180-Day Trade Plan Aug 20, 2026 Buying MELI on a Volume-Backed Breakout: Swing Trade Plan Aug 20, 2026 Iron Mountain: Buy the Data-Center Growth Story on Weakness — Tactical Long Aug 20, 2026 Gates Industrial: Buy the Rebound — Earnings Momentum Could Drive a Re-rating Aug 20, 2026